Ceftriaxone + sulbactam was approved as a broad-spectrum antibiotic to treat various bacterial infections.

Ceftriaxone+sulbactam injection is prescribed for various bacterial infections caused by susceptible organisms, including bacterial meningitis, community-acquired pneumonia, hospital-acquired pneumonia, acute otitis media (ear infection), intra-abdominal infections, complicated urinary tract infections, infections of bones and joints, complicated skin and soft tissue infections, gonorrhea, syphilis, bacterial endocarditis, and surgical prophylaxis.

Ceftriaxone+sulbactam injection is available in injection form in 1.5mg strength for intravenous and intramuscular use. This medication may be injected either into your muscles or veins by a trained healthcare provider. Your doctor will decide the most suitable dosage for your disease according to age and physical circumstances.

Serious side effects of this medication include severe allergic reactions such as rashes, itching, difficulty breathing, and fever. Seek medical attention immediately if you notice any of these symptoms. Common adverse reactions include irregularities in white blood cell count, like decreased leucocytes, increased eosinophils, and reduced platelet count. Patients may also experience loose stools, alterations in liver function, blood tests, and pain at the injection site. Another potential complication is thrombophlebitis, characterized by vein inflammation, which might cause discomfort and pain at the injection site. It is important to promptly report any of these symptoms to your healthcare provider for appropriate evaluation and guidance.

Do not take this medication if you are allergic to ceftriaxone, other cephalosporins, or penicillins. It is not recommended for premature babies or newborns (up to 28 days old) with blood issues, jaundice, or those under calcium-containing medications. 

Before taking ceftriaxone, consult your healthcare provider if you had calcium-containing medications, antibiotic-related diarrhea, gut issues like colitis, liver or kidney issues, gallstones, kidney stones, anemia, following a low sodium diet, or experienced symptoms like rash, blistering, or high fever. Transparent communication with your doctor about your medical history and medications is vital for safely using these injections.

If you are pregnant, planning to conceive, or breastfeeding, consult your doctor before using Ceftriaxone+Sulbactam, as its administration is determined only if essential by your healthcare provider. Inform your doctor if you have liver problems since it is used cautiously in liver patients, and your doctor may determine dose adjustments based on the severity of your liver disease. During the treatment, avoid alcohol, as it can interact with the medication, causing dizziness. Also, refrain from driving or operating machinery if you experience dizziness due to the injection. Always seek advice from your doctor for personalized guidance.

Ceftriazone+sulbactam injection is recommended only in children of 1 year of age or older. You have been prescribed this combination medication to treat bacterial infections, even in cases where you have developed resistance. Complete the entire prescribed course, even if you begin to feel better. If you stop it early, the infection might return and become harder to treat because the bacteria could develop resistance to the medicine.

Be aware that diarrhea might occur as a side effect. You can minimize this by taking probiotics such as yogurt, other fermented foods, and dietary supplements alongside ceftriaxone+sulbactam. You must talk to your doctor if you notice bloody stools or experience abdominal cramps.

Remember to take the medication with food and drink plenty of fluids to prevent an upset stomach. If you experiance an itchy rash, swelling of the face, throat, or tongue or experience difficulty breathing while taking Ceftriaxone + Sulbactam, stop taking the medication and contact your doctor immediately.

1. CP Pharmaceuticals Ltd, Electronic medicines compendium (EMC), [Revised on Jun 2022], [Accessed on 7th Oct 2023], https://www.medicines.org.uk/emc/product/1361/pil
2. Nitin Lifesciences Ltd, US Food and Drug Administration (FDA), [Revised on Sept 2022], [Accessed on 7th Oct 2023], https://bluecrosslabs.com/wp-content/uploads/2021/01/EXTACEF-XL1_5g-Injection-PI-Sep2022.pdf
3. KD Tripathi, Essentials of Medical Pharmacology, Antimicrobial drugs, 8th edition, 2019, 778
4. Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Chemotherapy of Infectious Diseases,13th edition, 2018, 1033- 1036

The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.